News - Simcere Pharmaceutical

Filter

Current filters:

Simcere Pharmaceutical

Popular Filters

Bristol-Myers and Simcere agree to co-develop/commercialize Orencia SC in China

14-06-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyBristol-Myers SquibbLicensingOrenciaPharmaceuticalSimcere Pharmaceutical

Adcock Ingram closes Indian acquisition; Simcere sheds Shanghai Celgen stake

22-01-2013

South Africa's largest health care company Adcock Ingram (AIP: SJ) has announced the completion of the…

Adcock IngramAsia-PacificCosme FarmaGenericsMergers & AcquisitionsShanghai Celgen Bio-PharmaceuticalsSimcere Pharmaceutical

Bristol-Myers expands partnerships with Simcere and NeurOp

15-12-2011

include a second collaboration in a different therapeutic area. Financial terms were not disclosed.

Bristol-Myers SquibbCardio-vascularLicensingNeurologicalNeurOpPharmaceuticalResearchSimcere Pharmaceutical

Merck & Co sets up China marketing JV with Simcere

22-07-2011

US pharma giant Merck & Co (NYSE: MRK) has signed a framework agreement with leading Chinese drugmaker…

Asia-PacificCardio-vascularDiabetesGenericsMarkets & MarketingMerck & CoPharmaceuticalSimcere Pharmaceutical

Company Spotlight

Fibrotech

Fibrotech

Back to top